Guanhao Biotech Co

Guanhao Biotech Co Interest Coverage

The Interest Coverage Ratio of Guanhao Biotech Co (300238.SZ) as of Oct 31, 2026 is 126.48. In the previous year, Interest Coverage Ratio was 7.94 — a change of 1,493.77% (higher).

Interest Coverage

126.48

YoY

1,493.77%

Last updated:

Interest Coverage Ratio of Guanhao Biotech Co is 2024 126.48 . Interest Coverage Ratio of Guanhao Biotech Co was 2023 7.94 . It decreases by 1,493.77% higher compared to the previous year.

The Guanhao Biotech Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
3.45 CNY
Jan 1, 2018
3.43 CNY
Jan 1, 2019
-24.84 CNY
Jan 1, 2020
3.51 CNY
Jan 1, 2021
9.60 CNY
Jan 1, 2022
-18.49 CNY
Jan 1, 2023
7.94 CNY
Jan 1, 2024
126.48 CNY
The Guanhao Biotech Co Interest Coverage history
YEARInterest CoverageYoY
126.48+1,493.77%
7.94-142.92%
-18.49-292.67%
9.60+173.21%
3.51-114.14%
-24.84-824.09%
3.43-0.70%
3.45-12.76%
3.96-85.88%
28.03+229.16%
8.52—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Guanhao Biotech Co Stock analysis

What does Guanhao Biotech Co do? Guanhao Biotech Co Ltd develops and sells regenerative medical materials and implant devices, including biological dura mater patches, chest general surgery department patching membranes (type P and type B), asepsis biological wound-surface protection membranes, type B dura matrix, and intraocular lenses. The company generates revenue through the sale of these products to healthcare providers and medical institutions. Its primary customers are hospitals and surgical departments requiring advanced regenerative solutions for wound care and ophthalmic procedures. The firm also offers related technological services as part of its product portfolio. The company focuses on regenerative medical applications, targeting segments such as neurosurgery, general surgery, and ophthalmology. Its product range addresses specific clinical needs, including dura mater repair, wound protection, and vision correction. By providing specialized medical materials, Guanhao Biotech serves healthcare facilities seeking innovative solutions for patient recovery and surgical outcomes. Guanhao Biotech's core business revolves around the production and distribution of high-value medical devices and materials. The firm's revenue streams are derived from direct sales of its regenerative medical products and associated technological services. Key segments include hospitals, surgical departments, and ophthalmic clinics that utilize its specialized membranes and lenses for patient care. Guanhao Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Guanhao Biotech Co stock

Interest Coverage Ratio of Guanhao Biotech Co is 126.48 in 2024.

Interest Coverage Ratio of Guanhao Biotech Co changed from 7.94 to 126.48, representing a 1,493.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Guanhao Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Guanhao Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Guanhao Biotech Co

All Key Metrics — Guanhao Biotech Co